Biosimilars Market Size, Share, Growth, and Regional Forecast, 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Biosimilars Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Regulatory Landscape
   2. Product Adoption Analysis
   3. Value Chain Analysis
   4. Key Deals and Mergers
   5. PESTLE Analysis
   6. Porter’s Five Force Analysis
4. Global Biosimilars Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
   3. Global Biosimilars Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
         1. Monoclonal antibodies (mAbs)
         2. Erythropoietins (EPOs)
         3. Insulin biosimilars
         4. Growth Factors
         5. Others
      4. Market Attractiveness Analysis: Drug Class
   4. Global Biosimilars Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
         1. Hematology
         2. Growth Hormone Deficiency
         3. Oncology
         4. Autoimmune Disorders 
         5. Diabetes Mellitus 
         6. Others
      4. Market Attractiveness Analysis: Application
   5. Global Biosimilars Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
         1. Hospital Pharmacies
         2. Online Pharmacies
         3. Retail Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
5. Global Biosimilars Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
   3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Biosimilars Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Application
      4. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Monoclonal antibodies (mAbs)
      2. Erythropoietins (EPOs)
      3. Insulin biosimilars
      4. Growth Factors
      5. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Hematology
      2. Growth Hormone Deficiency
      3. Oncology
      4. Autoimmune Disorders 
      5. Diabetes Mellitus 
      6. Others
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Dental Clinics
      2. Dental Hospitals
      3. Academic & Research Institutes
      4. Others
   7. Market Attractiveness Analysis
7. Europe Biosimilars Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Application
      4. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Monoclonal antibodies (mAbs)
      2. Erythropoietins (EPOs)
      3. Insulin biosimilars
      4. Growth Factors
      5. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Hematology
      2. Growth Hormone Deficiency
      3. Oncology
      4. Autoimmune Disorders 
      5. Diabetes Mellitus 
      6. Others
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Dental Clinics
      2. Dental Hospitals
      3. Academic & Research Institutes
      4. Others
   7. Market Attractiveness Analysis
8. East Asia Biosimilars Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Application
      4. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Monoclonal antibodies (mAbs)
      2. Erythropoietins (EPOs)
      3. Insulin biosimilars
      4. Growth Factors
      5. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Hematology
      2. Growth Hormone Deficiency
      3. Oncology
      4. Autoimmune Disorders 
      5. Diabetes Mellitus 
      6. Others
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Dental Clinics
      2. Dental Hospitals
      3. Academic & Research Institutes
      4. Others
   7. Market Attractiveness Analysis
9. South Asia & Oceania Biosimilars Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Application
      4. By Distribution Channel
   3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Monoclonal antibodies (mAbs)
      2. Erythropoietins (EPOs)
      3. Insulin biosimilars
      4. Growth Factors
      5. Others
   5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Hematology
      2. Growth Hormone Deficiency
      3. Oncology
      4. Autoimmune Disorders 
      5. Diabetes Mellitus 
      6. Others
   6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Dental Clinics
      2. Dental Hospitals
      3. Academic & Research Institutes
      4. Others
   7. Market Attractiveness Analysis
10. Latin America Biosimilars Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Drug Class
       3. By Application
       4. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
       1. Monoclonal antibodies (mAbs)
       2. Erythropoietins (EPOs)
       3. Insulin biosimilars
       4. Growth Factors
       5. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
       1. Hematology
       2. Growth Hormone Deficiency
       3. Oncology
       4. Autoimmune Disorders 
       5. Diabetes Mellitus 
       6. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       1. Dental Clinics
       2. Dental Hospitals
       3. Academic & Research Institutes
       4. Others
    7. Market Attractiveness Analysis
11. Middle East & Africa Biosimilars Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Drug Class
       3. By Application
       4. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
       1. Monoclonal antibodies (mAbs)
       2. Erythropoietins (EPOs)
       3. Insulin biosimilars
       4. Growth Factors
       5. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
       1. Hematology
       2. Growth Hormone Deficiency
       3. Oncology
       4. Autoimmune Disorders 
       5. Diabetes Mellitus 
       6. Others
    6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       1. Dental Clinics
       2. Dental Hospitals
       3. Academic & Research Institutes
       4. Others
    7. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Pfizer Inc.
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Sandoz International GMBH
       3. Eli Lily & Company
       4. Hospira Inc.
       5. Amgen, Inc.
       6. Biocon Ltd.
       7. Cipla Ltd.
       8. Teva Pharmaceutical Industries, Ltd.
       9. Dr. Reddy’s Laboratories Ltd.
       10. Celltrion, Inc.
       11. Stada Arzeimittel Ag
       12. Mylan, Inc.
       13. Wockhardt Ltd.
       14. Others
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations